Limiting dilution assays with YFP+ AML cells from primary transplant recipients revealed that the frequency of functional WT LICs was 1 in 59, which was approximately 8.3-fold higher than that of P2x1-null control cells (1 in 491; Fig. 1J and Table S1). The gene discussed is P2RX1; the disease is acute myeloid leukemia.